Clene (CLNN) director Reed N. Wilcox receives grant of 3,306 options

Rhea-AI Filing Summary

Clene Inc. director Reed N. Wilcox reported an equity award in the form of stock options. He was granted options covering 3,306 shares of common stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share.

The options vest immediately upon grant, giving him the right to purchase these shares at the stated exercise price. Following this grant, his directly held derivative securities position from this option award is reported as 3,306 options.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WILCOX REED N

(Last) (First) (Middle)

6550 SOUTH MILLROCK DRIVE

SUITE G50

(Street)

SALT LAKE CITY UT 84121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
stock option	$4.73	02/19/2026		A		3,306		(1)	02/18/2036	common stock	3,306	$0	3,306	D

Explanation of Responses:

1. This option was granted on February 19, 2026 as an option for 3,306 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The options vest immediately upon grant.

	/s/ Jerome T. Miraglia POA	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Clene (CLNN) director Reed N. Wilcox report?

Clene director Reed N. Wilcox reported receiving a stock option grant. The award covers 3,306 shares of Clene common stock, granted under the Amended 2020 Stock Plan, and is recorded as a derivative security position in his direct ownership.

How many Clene (CLNN) shares are covered by Reed N. Wilcox’s new option grant?

The option grant to Reed N. Wilcox covers 3,306 shares of Clene common stock. This entire amount was granted on February 19, 2026, and is reported as his total directly held derivative securities from this specific option award.

What is the exercise price of Reed N. Wilcox’s Clene (CLNN) stock options?

The exercise price of Reed N. Wilcox’s Clene stock options is $4.73 per share. This price is the amount he would pay per share to convert the options into common stock, according to the terms disclosed for this award.

When do Reed N. Wilcox’s newly granted Clene (CLNN) options vest?

The newly granted Clene stock options to Reed N. Wilcox vest immediately upon grant. This means he is fully vested in all 3,306 optioned shares as of the grant date, with no additional waiting or service-based vesting period required.

Under which plan were Reed N. Wilcox’s Clene (CLNN) options granted?

Reed N. Wilcox’s options were granted under the Clene Inc. Amended 2020 Stock Plan. This plan governs the terms of the stock option award, including the 3,306-share grant, the $4.73 exercise price, and the immediate vesting feature described in the disclosure.

How many Clene (CLNN) derivative securities does Reed N. Wilcox hold after this grant?

After this grant, Reed N. Wilcox is reported as directly holding 3,306 derivative securities from this option award. This figure matches the number of shares covered by the option grant, reflecting his position following the February 19, 2026 transaction.